Roche Receives CE Mark for Accu-Chek SugarView Smartphone App
The app will enable broader access to therapy-relevant information for non-insulin-dependent people with type 2 diabetes or prediabetes.
Read MorePosted by | Feb 7, 2020 | POC Instruments, Point-of-Care |
The app will enable broader access to therapy-relevant information for non-insulin-dependent people with type 2 diabetes or prediabetes.
Read MorePosted by | Dec 30, 2019 | Microarray Systems, POC Instruments, Point-of-Care |
SpeeDx and the QuantuMDx Group are collaborating with the Foundation for Innovative New Diagnostics to assess the feasibility of developing low-cost, point-of-care tests for common sexually transmitted infections.
Read MorePosted by Steve Halasey | Nov 12, 2019 | Allergy & Autoimmune, Point-of-Care |
The company will use the funds to develop and market near-patient, 2- to 5-minute tests to detect and monitor biomarkers for inflammatory and autoimmune diseases and for metabolic syndromes.
Read MorePosted by Steve Halasey | Oct 21, 2019 | Immunoassay, POC Rapid Assays, Point-of-Care, Sepsis |
To detect emergent sepsis, the study aims to develop a rapid diagnostic based on multiple biomarkers.
Read MorePosted by Steve Halasey | Oct 21, 2019 | Prostate |
The POC test would immediately help prostate cancer patients who have undergone radical prostatectomy but have positive surgical margins.
Read More